tiprankstipranks
Kraig Biocraft Laboratories Inc (KBLB)
OTHER OTC:KBLB
US Market
Holding KBLB?
Track your performance easily

Kraig Biocraft Laboratories (KBLB) Income Statement

101 Followers

Kraig Biocraft Laboratories Income Statement

Last quarter (Q ), Kraig Biocraft Laboratories's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Kraig Biocraft Laboratories's net income was $-433.20K. See Kraig Biocraft Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 2.65M$ 2.61M$ 2.12M$ 2.76M$ 4.53M$ 2.62M
Operating Income
$ -3.55M$ -2.61M$ -2.12M$ -2.76M$ -4.53M$ -2.62M
Net Non Operating Interest Income Expense
$ 509.36K$ 375.10K$ 1.72M$ -238.11K$ 31.08K$ 6.37K
Other Income Expense
$ 23.57K$ -39.89K$ 38.00$ -77.10K$ 2.60M-
Pretax Income
$ -3.87M$ -3.03M$ -3.84M$ -8.05M$ -4.97M$ -2.91M
Tax Provision
-----$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -3.87M$ -3.03M$ -3.84M$ -8.05M$ -4.97M$ -2.91M
Basic EPS
---$ -0.01$ -0.01-
Diluted EPS
---$ -0.01$ -0.01-
Basic Average Shares
$ 4.15B$ 1.03B$ 974.31M$ 877.61M$ 848.65M$ 835.59M
Diluted Average Shares
$ 4.15B$ 1.03B$ 974.31M$ 877.61M$ 848.65M$ 835.59M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.65M$ 2.61M$ 2.12M$ 2.76M$ 4.53M$ 2.62M
Net Income From Continuing And Discontinued Operation
$ -3.87M$ -3.03M$ -3.84M$ -8.05M$ -4.97M$ -2.91M
Normalized Income
$ -2.90M$ -2.22M-$ -6.72M--
Interest Expense
------
EBIT
$ -2.89M$ -2.55M$ -3.23M$ -7.39M$ -4.58M$ -2.62M
EBITDA
$ -2.86M$ -2.52M$ -3.20M$ -7.36M$ -4.56M$ -2.58M
Currency in USD

Kraig Biocraft Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis